1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Non-Opioid Pain Patch Market
2.2. Global Non-Opioid Pain Patch Market, By Patch, 2023 (US$ Million)
2.3. Global Non-Opioid Pain Patch Market, By Distribution Channel, 2023 (US$ Million)
2.4. Global Non-Opioid Pain Patch Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Non-Opioid Pain Patch Market: Competitive Analysis
3.1. Market Positioning of Key Non-Opioid Pain Patch Market Vendors
3.2. Strategies Adopted by Non-Opioid Pain Patch Market Vendors
3.3. Key Industry Strategies
4. Non-Opioid Pain Patch Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Non-Opioid Pain Patch Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Lidocaine Patches
5.3.2. Diclofenac Patches
5.3.3. Capsaicin Patches
5.3.4. Methyl Salicylate Patches
5.3.5. Others

6. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Hospital Pharmacy
6.3.2. Retail Pharmacy/Independent Pharmacy
6.3.3. E-commerce/ Online Pharmacy


7. North America Non-Opioid Pain Patch Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
7.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.Non-Opioid Pain Patch Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
7.4.1.1.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
7.4.1.2.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
7.4.1.3.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)

8. UK and European Union Non-Opioid Pain Patch Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.Non-Opioid Pain Patch Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.1.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.2.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.3.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.4.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.5.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
8.4.1.6.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)

9. Asia Pacific Non-Opioid Pain Patch Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.Non-Opioid Pain Patch Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.1.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.2.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.3.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.4.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.5.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
9.4.1.6.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)

10. Latin America Non-Opioid Pain Patch Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
10.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.Non-Opioid Pain Patch Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
10.4.1.1.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
10.4.1.2.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
10.4.1.3.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)

11. Middle East and Africa Non-Opioid Pain Patch Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
11.3. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.Non-Opioid Pain Patch Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
11.4.1.1.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
11.4.1.2.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Non-Opioid Pain Patch Market: By Patch, 2022-2032, USD (Million)
11.4.1.3.2. Non-Opioid Pain Patch Market: By Distribution Channel, 2022-2032, USD (Million)

12. Company Profile
12.1. Teh Seng Pharmaceutical Mfg. Co., Ltd.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Endo Pharmaceuticals Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Teikoku Seiyaku Co.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Allergan
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Hisamitsu Pharmaceutical Co. Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. GlaxoSmithKline plc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Mylan N.V.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. IBSA Institut Biochimque SA, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Acorda Therapeutics
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Others
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives